The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zavedos 10 mg Powder for Solution for Injection

Pfizer Healthcare IrelandPA0822/142/004

Main Information

Trade NameZavedos 10 mg Powder for Solution for Injection
Active SubstancesIdarubicin hydrochloride
Dosage FormPowder for solution for injection
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/142/004

Group Information

ATC CodeL01DB Anthracyclines and related substances
L01DB06 idarubicin


License statusWithdrawn
Withdrawn Date08/11/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone.
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back